Medico Intercontinental Ltd.

As of June 30, 2026, Medico Intercontinental Ltd. carries a market capitalization of 296.45M, placing it among publicly traded companies globally. Its enterprise value stands at 296.45M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Medico Intercontinental Ltd. has 9.98M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Medico Intercontinental Ltd. trades at an EV/EBITDA multiple of 18.36 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.36 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 296.45M versus a market cap of 296.45M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Medico Intercontinental Ltd. recorded 16.62M in income tax expense. The company reported a pretax loss of -109.78M and -54.05M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Medico Intercontinental Ltd.'s stock has declined approximately 30.73% over the past 52 weeks. The 50-day moving average sits at 26.35, while the 200-day moving average is 28.88.

Over the twelve months ended June 30, 2026, Medico Intercontinental Ltd. generated 834.41M in revenue and converted that into -54.05M in net income, yielding earnings per share of -12.52. EBITDA reached 16.15M, while operating income came in at -44.06M.

Over the twelve months ended June 30, 2026, Medico Intercontinental Ltd. posted a gross margin of 24.13, reflecting its pricing power and cost economics. The operating margin of -5.28 and net profit margin of -6.48 provide insight into operational efficiency.